Mineralocorticoid Receptor Antagonism for the Treatment of AF and HFpEF: Preserving Hope
- PMID: 30078393
- DOI: 10.1016/j.jchf.2018.06.010
Mineralocorticoid Receptor Antagonism for the Treatment of AF and HFpEF: Preserving Hope
Keywords: atrial fibrillation; heart failure; outcomes; spironolactone.
Comment on
-
Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: The TOPCAT Trial.JACC Heart Fail. 2018 Aug;6(8):689-697. doi: 10.1016/j.jchf.2018.05.005. Epub 2018 Jul 11. JACC Heart Fail. 2018. PMID: 30007557 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical